Weichun Guo
4PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 28, 2025
TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT/mTOR pathway activation through ubiquitination of FTO.Wenda Liu, Di Zheng, Xinghan Huang
|Oct 03, 2023
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.Zhun Wei, Kezhou Xia, Di Zheng
|Aug 17, 2023
TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling.Kezhou Xia, Di Zheng, Zhun Wei
|Jul 03, 2018
Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.Guo Dai, Shuang Deng, Weichun Guo
Pageof 1
